Kanter Biotech Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2010.
2010 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Kanter Biotech Private Limited

Kanter Biotech Private Limited, a struck off private limited company, was established on 30 April 2010 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232MH2010PTC202585. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.

Its leadership includes Naushad Ahmad (Director), Irshad Ahmed Rahim Ali Chaudhary (Director). Past directors included Ajeet Awadhesh Singh, Ilyas Ahmed, Abdul Hamid Chaudhary. It is based at 105,1St Floor,East West Industrial Centre Premises Andheri Kurla Road, Sakinaka, Andheri Ea, St, Mumbai, Maharashtra, 400072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MH2010PTC202585

  • Registration Number

    202585

  • Incorporation Date

    30 April 2010

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 16 Year, 29 Days
Company report

Kanter Biotech Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Kanter Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kanter Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Naushad Ahmad Director 09 Dec 2011 Current
Irshad Ahmed Rahim Ali Chaudhary Director 30 Apr 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Dec 2013 Past
Pramod Abcsdd Director 20 Apr 2012 Past
Pramod Abcsdd Director 20 Apr 2012 Past
Pramod Abcsdd Director 20 Apr 2012 Past
Pramod Abcsdd Director 20 Apr 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kanter Biotech.

Enhance accessibility to Kanter Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kanter Biotech revenue growth over time
Kanter Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kanter Biotech?

Unlock access to Kanter Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kanter Biotech?

Unlock and access historical data on people associated with Kanter Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kanter Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanter Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kanter Biotech
Recent Activity within the Organization
  • Director Appointment

    Naushad Ahmad was appointed as a Director was appointed as a Director on 09 Dec 2011 & has been associated with this company since 14 years 5 months . was recorded as a recent event.

  • Director Appointment

    Progress on Irshad Ahmed Rahim Ali Chaudhary was appointed as a Director was appointed as a Director on 30 Apr 2010 & has been associated with this company since 16 years 29 days . was documented.

  • Company Incorporation

    Kanter Biotech Private Limited was registered on 30 Apr 2010 with Roc Mumbai & aged 16 years 29 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kanter Biotech Private Limited?

The CIN of Kanter Biotech Private Limited is U24232MH2010PTC202585.

Where is Kanter Biotech Private Limited headquartered?

Kanter Biotech Private Limited is headquartered at 105,1St Floor,East West Industrial Centre Premises Andheri Kurla Road, Sakinaka, Andheri Ea, St, Mumbai, Maharashtra, 400072.

When was Kanter Biotech Private Limited incorporated?

Kanter Biotech Private Limited was incorporated on 30 April 2010.

Who are the current directors of Kanter Biotech Private Limited?

The current directors of Kanter Biotech Private Limited are

What is the primary industry of Kanter Biotech Private Limited?

The primary industry of Kanter Biotech Private Limited is Chemicals.

Is Kanter Biotech Private Limited a listed company?

Kanter Biotech Private Limited is unlisted.

What is the capital structure of Kanter Biotech Private Limited?

The authorized capital of Kanter Biotech Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available